pramipexole has been researched along with talipexole in 25 studies
| Studies (pramipexole) | Trials (pramipexole) | Recent Studies (post-2010) (pramipexole) | Studies (talipexole) | Trials (talipexole) | Recent Studies (post-2010) (talipexole) |
|---|---|---|---|---|---|
| 1,103 | 219 | 517 | 426 | 2 | 12 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (4.00) | 18.7374 |
| 1990's | 16 (64.00) | 18.2507 |
| 2000's | 5 (20.00) | 29.6817 |
| 2010's | 3 (12.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC | 1 |
| Furukawa, T; Kimura, H; Matsumoto, S; Nagashima, M; Yamada, K | 2 |
| Carter, AJ; Müller, RE | 1 |
| Furukawa, T; Matsumoto, S; Nagashima, M; Shirakawa, K; Yamada, K | 1 |
| Domae, M; Furukawa, T; Hanabusa, Y; Matsumoto, S; Yamada, K | 1 |
| Domae, M; Furukawa, T; Matsumoto, S; Nagashima, M; Shirakawa, K; Yamada, K | 1 |
| Bergstrom, DA; Gonzalez, AM; Huang, KX; Kreiss, DS; Sibley, DR; Walters, JR | 1 |
| Lin, MY; Walters, DE | 1 |
| Ferrari, F; Giuliani, D | 2 |
| Fibiger, HC; Jakubovic, A; Robertson, GS; Tham, CS; Wilson, C | 1 |
| Benkert, O; Müller-Siecheneder, F; Wetzel, H | 1 |
| Hanson, GD; Ichhpurani, N; Lau, YY; Selenka, JM; Talaat, R | 1 |
| Hanson, GD; Ichhpurani, N; Lau, YY | 1 |
| Domino, EF; Kohno, Y; Ni, L; Sasa, M; Zhang, H | 1 |
| Kitamura, Y; Kohno, Y; Nakazawa, M; Nomura, Y | 1 |
| Kakimura, JI; Kitamura, Y; Kohno, Y; Kosaka, T; Matsuoka, Y; Nomura, Y; Taniguchi, T | 1 |
| Kakimura, J; Kitamura, Y; Kohno, Y; Takata, K; Taniguchi, T | 1 |
| Kakimura, J; Kitamura, Y; Kohno, Y; Nomura, Y; Takata, K; Taniguchi, T | 1 |
| Daida, H; Hatano, T; Hattori, N; Iwama, Y; Komine-Kobayashi, M; Mizuno, Y; Mochizuki, H; Nakayama, T; Sakai, M; Urabe, T; Yamashiro, K | 1 |
| Akaike, A; Izumi, Y; Kume, T; Niidome, T; Oda, T; Takada-Takatori, Y | 1 |
| Arai, H; Hatta, K; Hattori, N; Ishikawa, K; Kamigaichi, R; Kubo, S; Mochizuki, H; Ogaki, K; Usui, C; Yokoyama, K | 1 |
| Kitamura, Y | 1 |
| Hiratochi, M; Ijiro, T; Kaidoh, K; Oana, F; Suzuki, T; Tsuchioka, A; Yamauchi, Y | 1 |
2 review(s) available for pramipexole and talipexole
| Article | Year |
|---|---|
Dopamine agonists in schizophrenia: a review.
Topics: Antipsychotic Agents; Autoreceptors; Azepines; Benzothiazoles; Dopamine Agonists; Humans; Pramipexole; Schizophrenia; Thiazoles | 1995 |
[Dopaminergic neuroprotection and reconstruction of neural network tiara].
Topics: Animals; Azepines; Benzothiazoles; Brain; Dopamine; Dopamine Agonists; Embryonic Stem Cells; Humans; Levodopa; Mice; Microglia; Nerve Net; Nerve Regeneration; Neuroprotective Agents; Parkinson Disease; Planarians; Pramipexole; Rats | 2010 |
23 other study(ies) available for pramipexole and talipexole
| Article | Year |
|---|---|
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate.
Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility | 2010 |
Hyperthermia induced by the dopamine D1 receptor agonist SK&F38393 in combination with the dopamine D2 receptor agonist talipexole in the rat.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Azepines; Benzothiazoles; Body Temperature; Dopamine Agents; Fever; Male; Pramipexole; Rats; Rats, Wistar; Receptors, Cell Surface; Receptors, Dopamine D1; Receptors, Dopamine D2; Thiazoles | 1992 |
Pramipexole, a dopamine D2 autoreceptor agonist, decreases the extracellular concentration of dopamine in vivo.
Topics: 3,4-Dihydroxyphenylacetic Acid; Analysis of Variance; Animals; Azepines; Benzothiazoles; Chromatography, High Pressure Liquid; Corpus Striatum; Dialysis; Dopamine; Dopamine Agents; Dopamine Antagonists; Extracellular Space; Homovanillic Acid; Male; Pramipexole; Rats; Rats, Inbred Strains; Sulpiride; Thiazoles | 1991 |
Potentiation of yawning responses to the dopamine receptor agonists B-HT 920 and SND 919 by pindolol in the rat.
Topics: Adrenergic beta-Antagonists; Animals; Azepines; Benzothiazoles; Dose-Response Relationship, Drug; Male; Pindolol; Pramipexole; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D2; Thiazoles; Yawning | 1990 |
Possible involvement of differing classes of dopamine D-2 receptors in yawning and stereotypy in rats.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Azepines; Benzothiazoles; Dopamine Agents; Male; Pramipexole; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D2; Stereotyped Behavior; Thiazoles; Yawning | 1990 |
Decrease of prolactin secretion via stimulation of pituitary dopamine D-2 receptors after application of talipexole and SND 919.
Topics: Animals; Azepines; Benzamides; Benzothiazoles; Dopamine Antagonists; Dose-Response Relationship, Drug; Estrogen Antagonists; Hyperprolactinemia; Injections, Subcutaneous; Male; Perfusion; Pituitary Gland, Anterior; Pramipexole; Prolactin; Radioimmunoassay; Rats; Rats, Inbred Strains; Receptors, Dopamine D2; Thiazoles | 1990 |
Occurrence of yawning and decrease of prolactin levels via stimulation of dopamine D2-receptors after administration of SND 919 in rats.
Topics: alpha-Methyltyrosine; Animals; Azepines; Behavior, Animal; Benzothiazoles; Dopamine Agents; Male; Methyltyrosines; Piperidines; Pramipexole; Prolactin; Rats; Rats, Inbred Strains; Receptors, Dopamine; Thiazoles; Yawning | 1989 |
Dopamine receptor agonist potencies for inhibition of cell firing correlate with dopamine D3 receptor binding affinities.
Topics: Aminoquinolines; Animals; Apomorphine; Azepines; Benzothiazoles; Binding, Competitive; CHO Cells; Cricetinae; Dopamine Agonists; Dose-Response Relationship, Drug; Ergolines; Imidazoles; Male; Neurons; Phenethylamines; Piperidines; Pramipexole; Quinolines; Quinpirole; Rats; Rats, Sprague-Dawley; Receptors, Dopamine; Receptors, Dopamine D2; Receptors, Dopamine D3; Structure-Activity Relationship; Substantia Nigra; Tetrahydronaphthalenes; Thiazoles; Thiophenes; Transfection | 1995 |
Dopamine D2 autoreceptors in rats are behaviorally functional at 21 but not 10 days of age.
Topics: Aging; Aminoquinolines; Animals; Apomorphine; Azepines; Behavior, Animal; Benzothiazoles; Dopamine Agonists; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Male; Motor Activity; Piperidines; Pramipexole; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Thiazoles | 1994 |
Influence of idazoxan on the dopamine D2 receptor agonist-induced behavioural effects in rats.
Topics: Adrenergic alpha-Antagonists; Animals; Azepines; Behavior, Animal; Benzothiazoles; Dioxanes; Dopamine Agents; Dose-Response Relationship, Drug; Idazoxan; Lisuride; Male; Pramipexole; Rats; Rats, Wistar; Receptors, Dopamine D2; Stereotyped Behavior; Thiazoles | 1993 |
In vivo comparisons of the effects of quinpirole and the putative presynaptic dopaminergic agonists B-HT 920 and SND 919 on striatal dopamine and acetylcholine release.
Topics: Acetylcholine; Animals; Azepines; Benzothiazoles; Corpus Striatum; Dopamine; Dopamine Agents; Ergolines; Male; Oxidopamine; Pramipexole; Quinpirole; Raclopride; Rats; Rats, Wistar; Receptors, Dopamine; Salicylamides; Thiazoles | 1993 |
Differential behavioral response to dopamine D2 agonists by sexually naive, sexually active, and sexually inactive male rats.
Topics: Animals; Azepines; Benzothiazoles; Copulation; Dopamine Agonists; Dose-Response Relationship, Drug; Ejaculation; Male; Pramipexole; Rats; Receptors, Dopamine D2; Sexual Behavior, Animal; Thiazoles | 1996 |
Determination of pramipexole (U-98,528) in human plasma by high-performance liquid chromatography with atmospheric pressure chemical ionization tandem mass spectrometry.
Topics: Administration, Oral; Atmospheric Pressure; Azepines; Benzothiazoles; Calibration; Chromatography, High Pressure Liquid; Dopamine Agonists; Humans; Linear Models; Mass Spectrometry; Pramipexole; Reference Standards; Reproducibility of Results; Sensitivity and Specificity; Thiazoles | 1996 |
Determination of pramipexole (U-98,528) in human plasma and urine by high-performance liquid chromatography with electrochemical and ultraviolet detection.
Topics: Azepines; Benzothiazoles; Calibration; Chromatography, High Pressure Liquid; Dopamine Agonists; Drug Stability; Electrochemistry; Humans; Linear Models; Osmolar Concentration; Pramipexole; Reference Standards; Reproducibility of Results; Sensitivity and Specificity; Spectrophotometry, Ultraviolet; Thiazoles; Time Factors | 1996 |
Talipexole or pramipexole combinations with chloro-APB (SKF 82958) in MPTP-induced hemiparkinsonian monkeys.
Topics: Animals; Antiparkinson Agents; Azepines; Basal Ganglia Diseases; Behavior, Animal; Benzazepines; Benzothiazoles; Dopamine Agents; Dopamine Agonists; Drug Interactions; Female; Macaca nemestrina; MPTP Poisoning; Parkinson Disease, Secondary; Pramipexole; Sleep; Thiazoles | 1997 |
Inhibitory effects of talipexole and pramipexole on MPTP-induced dopamine reduction in the striatum of C57BL/6N mice.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Animals; Azepines; Benzothiazoles; Bromocriptine; Dopamine; Dopamine Agents; Dopamine Agonists; Homovanillic Acid; In Vitro Techniques; Injections, Intraperitoneal; Male; Mice; Mice, Inbred C57BL; Neostriatum; Pramipexole; Synaptosomes; Thiazoles | 1997 |
Protective effects of the antiparkinsonian drugs talipexole and pramipexole against 1-methyl-4-phenylpyridinium-induced apoptotic death in human neuroblastoma SH-SY5Y cells.
Topics: 1-Methyl-4-phenylpyridinium; Antiparkinson Agents; Apoptosis; Azepines; Benzothiazoles; Bromocriptine; Bucladesine; Caspase 3; Caspases; Dopamine Agonists; Humans; Pramipexole; Proto-Oncogene Proteins c-bcl-2; Reactive Oxygen Species; Thiazoles; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 1998 |
Increase of bcl-2 protein in neuronal dendritic processes of cerebral cortex and hippocampus by the antiparkinsonian drugs, talipexole and pramipexole.
Topics: Animals; Antiparkinson Agents; Azepines; Benzothiazoles; Cell Membrane; Cerebral Cortex; Cytosol; Dendrites; Dopamine Agonists; Drug Administration Schedule; Hippocampus; Immunoblotting; Injections, Intraperitoneal; Male; Pramipexole; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Wistar; Thiazoles | 2000 |
Release and aggregation of cytochrome c and alpha-synuclein are inhibited by the antiparkinsonian drugs, talipexole and pramipexole.
Topics: 1-Methyl-4-phenylpyridinium; alpha-Synuclein; Antiparkinson Agents; Azepines; Benzothiazoles; Caspases; Cell-Free System; Cytochrome c Group; Cytosol; Deoxyadenine Nucleotides; Dose-Response Relationship, Drug; Enzyme Activation; Humans; Nerve Tissue Proteins; Organelles; Pramipexole; Synucleins; Thiazoles; Tumor Cells, Cultured | 2001 |
The frequency of cardiac valvular regurgitation in Parkinson's disease.
Topics: Aged; Aortic Valve Insufficiency; Azepines; Benzothiazoles; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Female; Humans; Male; Mitral Valve Insufficiency; Parkinson Disease; Pergolide; Pramipexole; Prevalence | 2008 |
Bromocriptine, a dopamine D(2) receptor agonist with the structure of the amino acid ergot alkaloids, induces neurite outgrowth in PC12 cells.
Topics: Animals; Azepines; Benzothiazoles; Blotting, Western; Bromocriptine; Dopamine Agonists; Dose-Response Relationship, Drug; Ergonovine; Ergot Alkaloids; Methylergonovine; Mitogen-Activated Protein Kinases; Neurites; PC12 Cells; Pramipexole; Rats; Receptors, Dopamine D2 | 2008 |
Effective control of catatonia in Parkinson's disease by electroconvulsive therapy: a case report.
Topics: Aged; Antiparkinson Agents; Azepines; Benzothiazoles; Cabergoline; Carbidopa; Catatonia; Catechols; Drug Therapy, Combination; Electroconvulsive Therapy; Ergolines; Female; Humans; Levodopa; Nitriles; Parkinson Disease; Pramipexole | 2009 |
Duration of drug action of dopamine D2 agonists in mice with 6-hydroxydopamine-induced lesions.
Topics: Animals; Antiparkinson Agents; Apomorphine; Azepines; Benzothiazoles; Cabergoline; Corpus Striatum; Disease Models, Animal; Dopamine Agonists; Ergolines; Indoles; Injections, Intraventricular; Male; Mice; Motor Activity; Oxidopamine; Parkinsonian Disorders; Pramipexole; Quinolines; Receptors, Dopamine D2; Tetrahydronaphthalenes; Thiophenes | 2015 |